Healthcare

Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast Updated Research Available

Opportunities in Type 2 Diabetic and Non diabetic Patients Treatment Boost Future Growth Potential

INDUSTRY
Healthcare

RELEASE DATE
15-May-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K8CB-01-00-00-00
SKU
HC03665-NA-MT_27665
Yes
SHARE

Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast
Published on: 15-May-2023 | SKU: HC03665-NA-MT_27665

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.

Most Type 1 diabetes patients—the main users of CGM—do not use these solutions due to their high costs and low reimbursements, especially in low- and middle-income countries. The adoption of these devices is very low in Asia-Pacific, Latin America, and the Middle East and Africa due to low accessibility, awareness, and affordability. A vast patient pool of diabetic and prediabetic patients needing treatment in these regions creates attractive opportunities for CGM vendors.

Vendors in the CMG solutions industry are partnering with various players across the diabetes treatment ecosystem to increase CGM adoption, data integration, and device combability. Examples of these partnerships are common between CGM vendors and insulin pen, insulin pump, and diabetes management platform providers. Technological advancements and strategic partnerships create new opportunities for CGM vendors.

Research Highlights:

  • Market size by revenue, covering historic and forecast data by segment (Homecare and Other Care Settings) and region (North America, Europe, Asia-Pacific, and the rest of the world)
  • Market drivers and restraints
  • Competitive landscape, including company market share analysis
  • Market opportunity size and new business models
  • Technological trends and growth opportunities for stakeholders

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Global Continuous Glucose Monitoring Solutions Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Global Burden of Diabetes

Diabetes Devices

Key Competitors

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast by End User

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis by Region

Pricing Trends and Forecast Analysis

CGM Devices by Components

Competitive Environment

Revenue Share

Revenue Share Analysis

CGM Solutions—Key Vendor Presence by Region

Changes in Regional Share of Diabetes

CGM Solutions—Diabetes by Region

China

India

Saudi Arabia

End Users—CGM

Diabetic Users

Diabetic Users (continued)

Prediabetes

Athletes and Fitness Management

Athletes and Fitness Management (continued)

Wellness—Weight Management

End Users—Summary

New Business Models

New Business Models (continued)

New Business Models (continued)

New Business Models (continued)

Noninvasive Monitoring Technologies

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Opportunity 1: Partnerships with Diabetes and Chronic Disease Solutions Providers

Growth Opportunity 1: Partnerships with Diabetes and Chronic Disease Solutions Providers (continued)

Growth Opportunity 2: Hospitals

Growth Opportunity 2: Hospitals (continued)

Growth Opportunity 3: Wellness and Nondiabetic Applications

Growth Opportunity 3: Wellness and Nondiabetic Applications (continued)

Growth Opportunity 4: Emerging Markets

Growth Opportunity 4: Emerging Markets (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • CMG Solutions: Total Health Expenditure Due To Diabetes, Global, 2007–2045
  • CMG Solutions: Diabetes Prevalence, 20–79 years, Global, 2007–2045
  • CGM Solutions: Growth Metrics, Global, 2022
  • CGM Solutions: Growth Drivers, Global, 2023–2027
  • CGM Solutions: Growth Restraints, Global, 2023–2027
  • CGM Solutions: Revenue Forecast, Global, 2020–2027
  • CGM Solutions: Revenue Forecast by End User, Global, 2020–2027
  • CGM Solutions: Revenue Forecast by Region, 2020–2027
  • CGM Solutions: Revenue Share by Component, Global, 2022
  • CGM Solutions: Revenue Share of Top Participants, Global, 2022
  • CGM Solutions: Key Vendor Presence in CGM by Region, 2023
  • CGM Solutions: Changes in Diabetes Prevalence by Region, Global, 2021 and 2045
  • CGM Solutions: Target Regions for Diabetes, Global, 2021 and 2045
  • CGM Solutions: Top 3 Reasons Hindering CGM Use in Tertiary Hospitals, China, 2021
  • CGM Solutions: User Frequency of Use of Diabetic Devices Among Diabetic Patients, Saudi Arabia, 2020–2021
  • CGM Solutions: CGM Adoption Challenges, Saudi Arabia, 2020–2021
  • CGM Solutions: CGM Satisfaction Level, Saudi Arabia, 2020–2021
  • CGM Solutions: Diabetes Prevalence by Type, Global, 2021
  • CGM Solutions: Insulin Users, Global, 2021 and 2030
  • CGM Solutions: Non-insulin Users, Global, 2021 and 2030
  • CGM Solutions: Number of hospital beds, Global, 2020 and 2030
  • Diabetes Devices and Services: Prediabetic Population by Region, Global, 2030
  • CGM Solutions: Sports Participation, TAM and Opportunity Size, Global, 2030
  • CGM Solutions: Athletes, TAM and Opportunity Size, Global, 2030
  • CGM Solutions: Number of People Who Are Overweight or Obese (BMI≥25kg/m²), Global, 2020–2030
  • Healthy Eating, Nutrition, and Weight Loss: Regional Share, Global, 2020
  • Diabetes Devices and Services: Noninvasive Glucose Measurement, Start-ups’ Progress, Global, 2022
  • Homecare Settings: Growth Metrics, Global, 2022
  • Homecare Settings: Revenue Forecast, Global, 2020–2027
  • Homecare Settings: Revenue Forecast by Region, 2020–2027
  • Hospitals and Other Care Settings: Growth Metrics, Global, 2022
  • Hospitals and Other Care Settings: Revenue Forecast, Global, 2020–2027
  • Hospitals and other care settings: Revenue Forecast by Region, 2020–2027

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.